Understanding how substance use affects brain development in adolescents
14/21 ABCD-USA Consortium: Research Project Site at CU Boulder
This study is looking at how using substances like alcohol, cannabis, and tobacco during teenage years affects brain development and mental health, and it's for kids aged 9-10 who will be followed over the years to see how these habits impact them as they grow up.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11078275 on NIH RePORTER |
What this research studies
This research investigates the impact of adolescent substance use, including alcohol, cannabis, and tobacco, on brain development and mental health. It involves a large cohort of children aged 9-10 years who will be followed over several years with regular assessments, including brain imaging and mental health evaluations. The study aims to understand how early substance use and environmental factors may influence neurodevelopment and lead to adverse outcomes. Participants will engage in minimal burden assessments through interviews and mobile monitoring to track their development and behaviors.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 9-10 years, particularly those with varying levels of substance use exposure.
Not a fit: Patients who are older than 10 years or do not have any history of substance use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention strategies for substance use and mental health issues in adolescents.
How similar studies have performed: Previous research has shown promising results in understanding the effects of adolescent substance use on brain development, making this study a continuation of established findings.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Banich, Marie T — University of Colorado
- Study coordinator: Banich, Marie T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.